Dr. Jayanta Chakrabarti

Consultant Surgical Oncology and Director
Chittaranjan National Cancer Institute, Kolkata

 

 

Read More.

Dr. Jaydip Bhaumik, Tata Medical Center

Gynaecological Oncology

His key research interests include preventive oncology in relation to cervical cancer.
Read More.

Dr. Dipanwita Banerjee

Joint Secretary Consultant Gynaecological Oncologist

Her current research focuses on strategies to eliminate cervical cancer in low resource setting and impact of HPV vaccination in cervical cancer screening.

Read More.

Dr. Tamohan Chaudhuri, SGCCRI

Consultant Clinical Oncologist

His key research interest includes clinical trials in cervical cancer.
Read More.

Dr. Chandan Mandal

Chief Scientist
I3T, Kolkata

His area of expertise resides mainly in Drug development, Translational Glycoimmunology, Proteomics and Glycomics in gynaecological cancer.
Read More.

Dr. Santu Saha

Scientist
New Castle University, UK

Santu Kumar Saha: He is currently pursuing an Newton Fellowship under the supervision of Professor Nicola Curtin at Newcastle University and in collaboration with Asima Mukhopadhyay, KolGOTrg.His work includes hypoxia and radiosensitization using PARP inhibitors in cervical cancers.
Read More.

Dr. Sweta Sharma Saha

Scientist
New Castle University, UK

Her previous research work includes basic and translational studies in cervical cancer. Currently she is working on DDR in ovarian cancer at Newcastle University and in collaboration with Asima Mukhopadhyay, KolGOTrg.
Read More.

Dr. Jayasri Das Sarma

Scientist
IISER, Kalyani

Her key research interest includes neuro-inflammation, immunology and cancer biology in relation to cervical and ovarian cancer.

Dr. Jyotirup Goswami

Consultant Clinical Oncologist
Narayana Superspecialty Hospital, Kolkata

Dr. Priyanka Singh

Consultant Gynaecological Oncologist
Asst. Professor, Dept. Of Gynae Oncology, SuperSpeciality Cancer Institute, Lucknow

Her previous and current research interest includes cervical cancer preventions.
Read More.

Dr. Gouri Shankar Bhattacharyya

Consultant Medical Oncologist
World Health Organization Steering Committee

He is a member of the World Health Organization Steering Committee for Oncology, member of ESMO Global Policy Committee, and coordinator for ESMO Global Opioid Policy Initiative.
Read More.

Prof. Sibsankar Roy

Scientist
CSIR-IICB

His key research interest includes cellular metabolism in ovarian cancer and therapeutic targets.

Dr. Manas Chakrabarti

Consultant Gynaecological Oncologist
Columbia Asia Hospital, Kolkata

His key research area focuses on quality of life assessment in cancers.

Dr. Sankhadeep Dutta

Senior Scientific Officer, Grade – II
Department of Oncogene Regulation, Chittaranjan NationalCancer Institute, Kolkata

His research primarily focuses on HPV associated cancer, deciphering its molecular mechanism of carcinogenesis for identification of epigenetic marks in early prediction of cervical preneoplastic and cancerous stages; deciphering the role of non-invasive biomarkers in High-Risk HPV associated Head and Neck Squamous Cell Carcinoma development and also evaluation of prevalence and oncogenic potential of novel HPV types. Read More.

Dr. Manisha Vernekar

Specialist – Gynecological Oncologist
Chittaranjan National Cancer Institute, Kolkata

Her key research area focuses on clinical trials in relation to ovarian and cervical cancer.
Read More.

Dr. Vilas D. Nasare

Senior Scientific Officer
Chittaranjan National Cancer Institute, Kolkata

His key research area focuses on basic and translational aspects of chemoresistance in ovarian and cervical cancer in correlation with micro RNA.
Read More.

Dr. Damayanti Das Ghosh

Scientist
SGCC&RI

Dr. Damayanti Das Ghosh is presently studying whether any correlation is present between stemness and presence of GOF mutant p53 and, whether such correlation is associated with chemoresistance in high grade serous ovarian cancer. Her second work is related to developing organoids from ovarian and cervical tumors. In cancer research, organoids can be used for both studying basic biology of the disease and for testing drug-sensitivity. She is also working on TCGA Data-mining on ovarian and endometrial cancer. Read More.

Dr. Anirban Dasgupta

Consultant Gynaecological Oncologist
Mission Hospital Durgapur and AIIMS, Kalyani

 

 

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Dr. Biswarup Basu

Senior Scientific Officer II
Dept of Neuroendocrinology & Experimental Hematology CNCI

 

 

Dr Biswarup Basu is Senior Scientific Officer at CNCI and his area of interest is deciphering neuronal regulations on cancer progression. He is engaged in identifying key proteins in autophagy and neuro-endocrine pathways that may serve as potential biomarkers and targets against cancer metastasis in breast and ovarian cancers. Dr Basu is also working on natural compounds with anticancer properties in ovarian tumor models. His other research interest involves the development of biomaterials to accelerate wound healing and facilitate sustained delivery of oral drugs. Read More.

 

 

Dr. Puja Chatterjee

Senior Clinical Fellow, Gynaecological Oncology
Department of Gyne Oncology, CNCI

 

 

Her key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Arunashis Mallick

Clinical Fellow
Gynecological Oncology, Tata Medical Center

 

 

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.

Dr.Bijoy Kar

Consultant Gynaecological Oncologist
KolGOTrg and GCRI Ahmedabad

 

 

His key research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Dr. Chandrima Ray

Senior Clinical Fellow
Gynaecological Oncology

 

 

 

Her research area focuses on clinical trials in relation to ovarian and cervical cancers.
Read More.

Dr. Shilpak Chatterjee

Senior Scientist
Cancer Biology and Inflammatory Disorder Division CSIR-Indian Institute of Chemical Biology, Kolkata

 

 

The major objective of his lab is to understand the mechanism (s) dampening the objective repose of the anti-tumor T cells in cancer,primarily focusing on:

  • To elucidate the role of cellular metabolisms in remodeling of the anti-tumor response of T cells.
  • Determine the crosstalk between metabolic adaptation and stress response pathways in modulating the therapeutic efficacy of anti-tumor T cell.
  • Determine the role of cellular metabolism in shaping up the epigenetic landscape of anti-tumor T cells.

Read More.